Background Background Neuroimaging studies
Neuroimaging studies have demonstrated changes in the have demonstrated changes in the dorsolateral prefrontal cortex (DLPFC) dorsolateral prefrontal cortex (DLPFC) and anterior cingulate cortex (ACC) in and anterior cingulate cortex (ACC) in major depression. major depression.
Aims Aims We investigated the expression of
We investigated the expression of cell adhesion molecules (CAMs) in the cell adhesion molecules (CAMs) in the prefrontal cortex in depression. prefrontal cortex in depression.
Method Method Immunohistochemistry to
Immunohistochemistry to localise CAMs in post-mortem tissue from localise CAMs in post-mortem tissue from 20 subjects with major depression and 20 20 subjects with major depression and 20 controls, and image analysis to quantify controls, and image analysis to quantify their expression. their expression.
Results

Results We found significant increases
We found significant increases in CAMs in the grey matter of the DLPFC in CAMs in the grey matter of the DLPFC in the depression group but no in the depression group but no comparable differences in the ACC or comparable differences in the ACC or occipital cortex.In the white matter there occipital cortex.In the white matter there was a non-significant increase in was a non-significant increase in intercellular adhesion molecule-1in the intercellular adhesion molecule-1in the DLPFC in the depression group but no DLPFC in the depression group but no increase in the other areas or for vascular increase in the other areas or for vascular cell adhesion molecule-1in any area.Paired cell adhesion molecule-1in anyarea.Paired tests showed specificity for the DLPFC in tests showed specificity for the DLPFC in the depression group only. the depression group only.
Conclusions Conclusions The increase in CAM
The increase in CAM expression in the DLPFC suggests an expression in the DLPFC suggests an inflammatory reaction and is consistent inflammatory reaction and is consistent with ischaemia. with ischaemia.
Declaration of interest Declaration of interest None.
None.
The 'vascular depression' hypothesis proThe 'vascular depression' hypothesis proposes that late-life depression is associated poses that late-life depression is associated with vascular disease affecting the frontalwith vascular disease affecting the frontalsubcortical circuitry, based on associations subcortical circuitry, based on associations between depression and vascular disease between depression and vascular disease (Alexopoulos (Alexopoulos et al et al, 1997) and magnetic , 1997) and magnetic resonance imaging studies in major depresresonance imaging studies in major depression, which have shown an increase in white sion, which have shown an increase in white matter lesions (WMLs) that may have a matter lesions (WMLs) that may have a vascular origin (O'Brien vascular origin (O'Brien et al et al, 1996) . The , 1996) . The WMLs appear to be most strongly assoWMLs appear to be most strongly associated with depression when they involve ciated with depression when they involve frontal-subcortical circuits, which reciprofrontal-subcortical circuits, which reciprocally link prefrontal areas (the dorsolateral cally link prefrontal areas (the dorsolateral prefrontal cortex (DLPFC) and the anterior prefrontal cortex (DLPFC) and the anterior cingulate cortex (ACC)) to the basal ganglia cingulate cortex (ACC)) to the basal ganglia (Greenwald (Greenwald et al et al, 1998) . This is consistent , 1998). This is consistent with positron emission tomography studies with positron emission tomography studies in depression, which have demonstrated in depression, which have demonstrated hypometabolism in the DLPFC (Bench hypometabolism in the DLPFC (Bench et al et al, 1992) and the ACC (Drevets , 1992 ) and the ACC (Drevets et al et al, , 1997) . This study tested whether ischaemic 1997). This study tested whether ischaemic changes occur in the brain in depression in changes occur in the brain in depression in the DLPFC and the ACC, by measuring the DLPFC and the ACC, by measuring two cell adhesion molecules (CAMs). The two cell adhesion molecules (CAMs). The expression of these CAMs is increased by expression of these CAMs is increased by ischaemia ischaemia in vitro in vitro (Kim, 1996) and in (Kim, 1996) and in human cerebral microvessels in the vicinity human cerebral microvessels in the vicinity of the infarct following ischaemic stroke of the infarct following ischaemic stroke (Lindsberg (Lindsberg et al et al, 1996 (Lindsberg et al et al, ). , 1996 .
METHOD METHOD Subjects Subjects
Brain tissue from 40 subjects was obtained Brain tissue from 40 subjects was obtained from the Neuropathology Department/ from the Neuropathology Department/ Newcastle Brain Tissue Bank. Permission Newcastle Brain Tissue Bank. Permission had been given for post-mortem research, had been given for post-mortem research, and ethical approval was granted for this and ethical approval was granted for this study. Cases consisted of 20 subjects who study. Cases consisted of 20 subjects who had had depression and 20 controls. Subhad had depression and 20 controls. Subjects with depression were included if they jects with depression were included if they were 60 years or over at death and had were 60 years or over at death and had suffered at least one well-documented suffered at least one well-documented episode of DSM-IV major depression episode of DSM-IV major depression (American Psychiatric Association, 1994) . (American Psychiatric Association, 1994) . Subjects were excluded if they had ever Subjects were excluded if they had ever met the DSM-IV criteria for dementia, met the DSM-IV criteria for dementia, schizophrenia or other psychotic disorders, schizophrenia or other psychotic disorders, a manic or hypomanic episode or a mood a manic or hypomanic episode or a mood disorder due to a general medical condidisorder due to a general medical condition. Subjects were also excluded if they tion. Subjects were also excluded if they met the neuropathological criteria for any met the neuropathological criteria for any known cause of dementia (such as Alzheiknown cause of dementia (such as Alzheimer's disease, vascular dementia or demenmer's disease, vascular dementia or dementia with Lewy bodies) or had evidence of tia with Lewy bodies) or had evidence of any other neurological disorder. Control any other neurological disorder. Control subjects were known to be capable of living subjects were known to be capable of living independently and met the same criteria independently and met the same criteria except that they had never suffered a except that they had never suffered a depressive episode. depressive episode. All subjects in the depression group had All subjects in the depression group had undergone extensive assessments, including undergone extensive assessments, including a full history, mental state examination, a full history, mental state examination, physical examination, screening blood tests, physical examination, screening blood tests, cognitive tests and, in some cases, computed cognitive tests and, in some cases, computed tomography or magnetic resonance imaging tomography or magnetic resonance imaging scans. All had received standard antidepresscans. All had received standard antidepressant treatment regimes, with selective sant treatment regimes, with selective serotonin reuptake inhibitors or tricyclic serotonin reuptake inhibitors or tricyclic antidepressants singly or often in combinaantidepressants singly or often in combination with other agents, and 11 had received tion with other agents, and 11 had received electroconvulsive therapy. No control subelectroconvulsive therapy. No control subject had taken any antidepressant or antiject had taken any antidepressant or antipsychotic medication. The case notes on psychotic medication. The case notes on all subjects were examined to see if they all subjects were examined to see if they had a history of hypertension sufficient to had a history of hypertension sufficient to need treatment with antihypertensive need treatment with antihypertensive medication. All subjects had had a full medication. All subjects had had a full post-mortem assessment (except one whose post-mortem assessment (except one whose body was unavailable for autopsy) and the body was unavailable for autopsy) and the post-mortem delay was recorded. post-mortem delay was recorded.
Tissue Tissue
After death the right hemisphere was fixed After death the right hemisphere was fixed in 10% formalin and the brains were disin 10% formalin and the brains were dissected in a standard manner. To obtain tissected in a standard manner. To obtain tissue blocks for analysis, tissue was selected sue blocks for analysis, tissue was selected from three areas: the DLPFC (Brodmann from three areas: the DLPFC (Brodmann areas (BA) 9 and 46), the ACC (BA 24) areas (BA) 9 and 46), the ACC (BA 24) and the occipital cortex (BA 19 and 39) as and the occipital cortex (BA 19 and 39) as a comparison area. The DLPFC blocks a comparison area. The DLPFC blocks were chosen by carefully selecting the corowere chosen by carefully selecting the coronal slice from each subject to include BA 9 nal slice from each subject to include BA 9 and 46 according to a standard map (Perry, and 46 according to a standard map (Perry, 1993) . Owing to the variation in humans, 1993). Owing to the variation in humans, this may have included BA 10 in some subthis may have included BA 10 in some subjects. The ACC block was taken from BA jects. The ACC block was taken from BA 24 just rostral to the genu of the corpus 24 just rostral to the genu of the corpus callosum or, occasionally, just including callosum or, occasionally, just including the rostral tip of the genu. These blocks the rostral tip of the genu. These blocks were chosen to examine the areas identified were chosen to examine the areas identified as reduced in function in depression in the as reduced in function in depression in the DLPFC (Bench DLPFC (Bench et al et al, 1992) and ACC , 1992) and ACC (Drevets (Drevets et al et al, 1997) . The occipital cortex , 1997). The occipital cortex block was chosen to determine whether block was chosen to determine whether any changes in the prefrontal areas were any changes in the prefrontal areas were specific for these areas or occurred throughspecific for these areas or occurred throughout the brain. These blocks were embedded out the brain. These blocks were embedded in paraffin wax, the duration of fixation of in paraffin wax, the duration of fixation of these large blocks was recorded and they these large blocks was recorded and they were sectioned using a sledge microtome were sectioned using a sledge microtome into 10-into 10-m mm sections (one per subject) on m sections (one per subject) on large slides (3 large slides (36 62 2'' ''). These slides were ). These slides were coded so that all analysis could be carried coded so that all analysis could be carried out blind to diagnosis. out blind to diagnosis.
Immunocytochemistry Immunocytochemistry
Sections were processed for immunoSections were processed for immunocytochemical localisation in a standard cytochemical localisation in a standard manner. Briefly, sections were dewaxed manner. Briefly, sections were dewaxed in xylene, rehydrated and microwaved in in xylene, rehydrated and microwaved in 0.01% citrate buffer (pH 6.0) to optimise 0.01% citrate buffer (pH 6.0) to optimise antigen retrieval. They were immersed in antigen retrieval. They were immersed in hydrogen peroxide, blocked with an hydrogen peroxide, blocked with an appropriate serum and incubated for 1 h appropriate serum and incubated for 1 h at room temperature with the primary at room temperature with the primary antibody. The primary antibodies used antibody. The primary antibodies used were a polyclonal antibody to intercellular were a polyclonal antibody to intercellular adhesion molecule-1 (ICAM-1) (R&D adhesion molecule-1 (ICAM-1) (R&D Systems; 1:500 dilution), a polyclonal antiSystems; 1:500 dilution), a polyclonal antibody to vascular cell adhesion molecule-1 body to vascular cell adhesion molecule-1 (VCAM-1) (R&D Systems; 1:800 dilution) (VCAM-1) (R&D Systems; 1:800 dilution) and a monoclonal antibody to collagen and a monoclonal antibody to collagen IV (Sigma; 1:500 dilution). Immuno-IV (Sigma; 1:500 dilution). Immunocytochemistry was carried out using slides cytochemistry was carried out using slides with code numbers to ensure blindedness with code numbers to ensure blindedness and with a random order of depression and with a random order of depression and control cases. Slides were processed and control cases. Slides were processed together for each primary antibody in together for each primary antibody in order to ensure that the immunoorder to ensure that the immunocytochemistry conditions were the same cytochemistry conditions were the same for both groups. The expression of for both groups. The expression of ICAM-1 and VCAM-1 is increased by ICAM-1 and VCAM-1 is increased by ischaemia (Kim, 1996) in cerebral ischaemia (Kim, 1996) in cerebral endothelial cells endothelial cells in vitro in vitro and studies of and studies of human ischaemic stroke have also shown human ischaemic stroke have also shown increased ICAM-1 expression in the microincreased ICAM-1 expression in the microvessels in association with the stroke vessels in association with the stroke lesions (Lindsberg lesions (Lindsberg et al et al, 1996) . Both , 1996) . Both ICAM-1 and VCAM-1 were therefore ICAM-1 and VCAM-1 were therefore chosen as putative markers of cerebral chosen as putative markers of cerebral ischaemia. Collagen IV (a basement memischaemia. Collagen IV (a basement membrane protein) is a marker of the density brane protein) is a marker of the density of the microvascular tree and was measof the microvascular tree and was measured to determine whether any differences ured to determine whether any differences in ICAM-1 or VCAM-1 reflected alterain ICAM-1 or VCAM-1 reflected alterations in the whole vascular tree rather than tions in the whole vascular tree rather than in ICAM-1 or VCAM-1 expression in the in ICAM-1 or VCAM-1 expression in the vessels (Kalaria & Hedera, 1995) . Approvessels (Kalaria & Hedera, 1995) . Appropriate secondary antibodies were then priate secondary antibodies were then applied followed by avidin-biotinylated applied followed by avidin-biotinylated horseradish peroxidase complex (Vector horseradish peroxidase complex (Vector Laboratories Ltd) and diaminobenzidine Laboratories Ltd) and diaminobenzidine (DAB) as a chromagen. All sections were (DAB) as a chromagen. All sections were lightly counterstained with haematoxylin lightly counterstained with haematoxylin and were examined using a light microand were examined using a light microscope to check the quality of staining scope to check the quality of staining before proceeding to quantitative analysis. before proceeding to quantitative analysis.
Quantitative analysis Quantitative analysis
Analysis was conducted on one section per Analysis was conducted on one section per anatomical area per subject, based on calanatomical area per subject, based on calculations of the variability between fields culations of the variability between fields and between different immunocytochemand between different immunocytochemical assays. The mean coefficient of error ical assays. The mean coefficient of error for five fields (from five subjects) was for five fields (from five subjects) was 6.8% and there was very little difference 6.8% and there was very little difference whether fields were taken from one section whether fields were taken from one section per subject (mean coefficient of error per subject (mean coefficient of error¼ 6.6% for ten fields from five subjects) or 6.6% for ten fields from five subjects) or from two sections per subject run in differfrom two sections per subject run in different immunocytochemistry assays (mean ent immunocytochemistry assays (mean coefficient of error coefficient of error¼7.3% for ten fields, 7.3% for ten fields, five per section, from five subjects). five per section, from five subjects).
Images were captured using a Images were captured using a 6 610 10 objective lens on a Zeiss Axloplan 2 light objective lens on a Zeiss Axloplan 2 light microscope coupled to a three-chip CCD microscope coupled to a three-chip CCD true-colour video camera (JVC KY F55B), true-colour video camera (JVC KY F55B), producing a field size of 185 000 producing a field size of 185 000 m mm m 2 2 (0.185 mm (0.185 mm 2 2 ). For each antibody, five ). For each antibody, five images selected randomly were captured images selected randomly were captured from the grey matter and ten from the from the grey matter and ten from the white matter on each section from the white matter on each section from the DLPFC and the occipital cortex, and DLPFC and the occipital cortex, and ten from the grey matter and fifteen from ten from the grey matter and fifteen from the white matter in the ACC. Images were the white matter in the ACC. Images were obtained randomly by the operator selectobtained randomly by the operator selecting a field by moving the stage while not ing a field by moving the stage while not looking at the section. If the field was looking at the section. If the field was outside the area of interest (grey or white outside the area of interest (grey or white matter) then this was repeated until the matter) then this was repeated until the field included the required tissue. This field included the required tissue. This ensured that each field was selected indeensured that each field was selected independently of the microscopic appearance pendently of the microscopic appearance of its microvessels. They were analysed of its microvessels. They were analysed blind to diagnosis on a monitor using a blind to diagnosis on a monitor using a standard software program (Image Pro standard software program (Image Pro Plus, version 4.0; Media Cybernetics). This Plus, version 4.0; Media Cybernetics). This involved measuring the area of DAB staininvolved measuring the area of DAB staining, expressed as a percentage of the total ing, expressed as a percentage of the total image area (areal fraction), and then calcuimage area (areal fraction), and then calculating a mean score for the grey and white lating a mean score for the grey and white matter for each cortical area. The areal matter for each cortical area. The areal fraction was not obtained using thresholdfraction was not obtained using thresholding because this method was found to lead ing because this method was found to lead to inappropriate inclusion of structures to inappropriate inclusion of structures that were not stained with the CAM antithat were not stained with the CAM antibodies. Instead, the dropper method was bodies. Instead, the dropper method was used, in which the operator selected DABused, in which the operator selected DABstained microvessels by eye in each field stained microvessels by eye in each field according to their exact red-green-blue according to their exact red-green-blue colour characteristics; this avoided the colour characteristics; this avoided the thresholding problem of including other thresholding problem of including other structures. Interrater and intrarater reliabilstructures. Interrater and intrarater reliability ratings were calculated (from 48 images ity ratings were calculated (from 48 images on 16 patients) for the two raters using the on 16 patients) for the two raters using the intraclass correlation coefficient and the intraclass correlation coefficient and the coefficient of variation, respectively. coefficient of variation, respectively.
Statistical analysis Statistical analysis
Statistical comparisons were carried out Statistical comparisons were carried out using SPSS software (Version 9.0). Tests using SPSS software (Version 9.0). Tests for normality were conducted and unfor normality were conducted and unpaired, two-way Student's paired, two-way Student's t t-tests or -tests or Mann-Whitney tests were used, as approMann-Whitney tests were used, as appropriate, to compare ICAM-1 and VCAM-1 priate, to compare ICAM-1 and VCAM-1 expression in the depression and control expression in the depression and control groups. To examine whether any changes groups. To examine whether any changes in ICAM-1 and VCAM-1 expression in ICAM-1 and VCAM-1 expression showed specificity for the prefrontal areas, showed specificity for the prefrontal areas, paired paired t t-tests and Wilcoxon signed rank -tests and Wilcoxon signed rank tests were used, as appropriate, for withintests were used, as appropriate, for withingroup comparisons. Secondary analyses group comparisons. Secondary analyses were conducted to examine possible conwere conducted to examine possible confounders. These included comparison of founders. These included comparison of collagen IV expression in the two groups collagen IV expression in the two groups and possible effects of treatment and and possible effects of treatment and hypertension on CAM expression. Pearson hypertension on CAM expression. Pearson correlation coefficients, correlation coefficients, t t-tests or Mann--tests or MannWhitney tests, and analysis of variance were Whitney tests, and analysis of variance were used, as appropriate, for these analyses. used, as appropriate, for these analyses.
RESULTS RESULTS
Subjects' characteristics are given in Subjects' characteristics are given in Table 1 , which shows no significant differ- Table 1 , which shows no significant differences in age, post-mortem delay or duration ences in age, post-mortem delay or duration of fixation between the two groups. The of fixation between the two groups. The coefficients of variation were 3.9% for coefficients of variation were 3.9% for rater 1 and 9.8% for rater 2, and the intrarater 1 and 9.8% for rater 2, and the intraclass correlation coefficient was 0.97. class correlation coefficient was 0.97. Figures 1 and 2 show ICAM-1 and Figures 1 and 2 show ICAM-1 and VCAM-1 expression in the two groups VCAM-1 expression in the two groups and Figures 3 and 4 show ICAM-1 and and Figures 3 and 4 show ICAM-1 and VCAM-1 immunoreactivity, respectively. VCAM-1 immunoreactivity, respectively.
Comparison of depression Comparison of depression and control groups and control groups
The ICAM-1 expression was significantly The ICAM-1 expression was significantly higher in the depression group in both the higher in the depression group in both the grey matter ( grey matter (t t¼2. A Bonferroni correction was set at 0.017, based on testing three tion was set at 0.017, based on testing three areas in each subject, and the increase in the areas in each subject, and the increase in the grey matter of the DLPFC remained signifgrey matter of the DLPFC remained significant for both ICAM-1 and VCAM-1. Such icant for both ICAM-1 and VCAM-1. Such corrections were not made for using both corrections were not made for using both ICAM-1 and VCAM-1 or for assessing ICAM-1 and VCAM-1 or for assessing grey and white matter, because we had grey and white matter, because we had hypothesised hypothesised a priori a priori that these measures that these measures would be highly correlated and correcting would be highly correlated and correcting for these would have been too stringent. for these would have been too stringent.
Comparison of areas within groups Comparison of areas within groups
In the grey matter, paired In the grey matter, paired t t-tests showed -tests showed that ICAM-1 expression in the DLPFC in that ICAM-1 expression in the DLPFC in the depression subjects was highly signifithe depression subjects was highly significantly elevated compared with both the cantly elevated compared with both the ACC ( ACC (t t¼3.05, 3.05, P P¼0.01) and the occipital 0.01) and the occipital cortex ( cortex (t t¼2.72, 2.72, P P¼0.01), whereas there 0.01), whereas there was no difference between the ACC and was no difference between the ACC and the occipital cortex ( the occipital cortex (t t¼1.17, 1.17, P P¼0.26). 0.26). Similarly in the white matter, there was a Similarly in the white matter, there was a highly significant increase in ICAM-1 in highly significant increase in ICAM-1 in the DLPFC compared with the ACC the DLPFC compared with the ACC ( (t t¼3.85, 3.85, P P¼0.001) and occipital cortex 0.001) and occipital cortex ( (t t¼4.08, 4.08, P P¼0.001) but no difference be-0.001) but no difference between the ACC and the occipital cortex tween the ACC and the occipital cortex ( (t t¼1.77, 1.77, P P¼0.09). In contrast, in grey 0.09). In contrast, in grey matter in the control group there were no matter in the control group there were no significant differences between the DLPFC significant differences between the DLPFC and the ACC ( and the ACC (t t¼1.26, 1.26, P P¼0.22), the DLPFC 0.22), the DLPFC and the occipital cortex ( and the occipital cortex (t t¼1.71, 1.71, P P¼0.10) 0.10) or the ACC and the occipital cortex or the ACC and the occipital cortex ( (t t¼0.02, 0.02, P P¼0.98). In the white matter of 0.98). In the white matter of the control group there was a significant the control group there was a significant increase in ICAM-1 in the DLPFC increase in ICAM-1 in the DLPFC compared with the ACC ( compared with the ACC (t t¼2.59, 2.59, P P¼0.02) 0.02) but no significant differences between the but no significant differences between the DLPFC and the occipital cortex ( DLPFC and the occipital cortex (t t¼1.76, 1.76, P P¼0.10) or between the ACC and the occi-0.10) or between the ACC and the occipital cortex ( pital cortex (t t¼1.39, 1.39, P P¼0.18). Similarly for 0.18). Similarly for VCAM-1, there was a significant increase VCAM-1, there was a significant increase in the grey matter of the depression group in the grey matter of the depression group in the DLPFC compared with both the in the DLPFC compared with both the ACC ( ACC (Z Z¼7 73.44, 3.44, P P¼0.001) and the occi-0.001) and the occipital cortex ( pital cortex (Z Z¼7 71.98, 1.98, P P¼0.05) but not 0.05) but not in the ACC compared with the occipital in the ACC compared with the occipital cortex ( cortex (Z Z¼7 71.34, 1.34, P P¼0.18). In the white 0.18). In the white matter of the depression subjects VCAM-1 matter of the depression subjects VCAM-1 was highly significantly elevated in the was highly significantly elevated in the DLPFC compared with both the ACC DLPFC compared with both the ACC ( (Z Z¼7 73.58, 3.58, P P5 50.001) and the occipital 0.001) and the occipital cortex ( cortex (Z Z¼7 73.06, 3.06, P P¼0.002) but there 0.002) but there was no difference in VCAM-1 expression was no difference in VCAM-1 expression between the ACC and occipital cortex between the ACC and occipital cortex ( (Z Z¼7 71.53, 1.53, P P¼0.13). In contrast, in the 0.13). In contrast, in the control subjects there were no differences control subjects there were no differences in VCAM-1 expression in the grey matter in VCAM-1 expression in the grey matter between the DLPFC and the ACC between the DLPFC and the ACC ( (Z Z¼7 71.32, 1.32, P P¼0.19), the DLPFC and the 0.19), the DLPFC and the occipital cortex ( occipital cortex (Z Z¼7 70.85, 0.85, P P¼0.40) or the 0.40) or the ACC and the occipital cortex ( ACC and the occipital cortex (Z Z¼7 70.06, 0.06, P P¼0.96). In the control subjects' white 0.96). In the control subjects' white matter there was a significant elevation of matter there was a significant elevation of VCAM-1 in the DLPFC compared with VCAM-1 in the DLPFC compared with the ACC ( the ACC (Z Z¼7 72.20, 2.20, P P¼0.03) and a trend 0.03) and a trend towards significance between the DLPFC towards significance between the DLPFC and the occipital cortex ( and the occipital cortex (Z Z¼7 71.83, 1.83, P P¼0.07) but no difference between the 0.07) but no difference between the ACC and the occipital cortex ( ACC and the occipital cortex (Z Z¼7 70.43, 0.43, P P¼0.67). 0.67).
Assessment of potential Assessment of potential confounders confounders
There were no significant group differences There were no significant group differences in the expression of collagen IV in any area in the expression of collagen IV in any area in either grey matter ( in either grey matter (t t5 50. In the depression group we found no In the depression group we found no correlation between age of onset of deprescorrelation between age of onset of depression or any of the four significant outcome sion or any of the four significant outcome measures ( measures (r r5 50.224, 0.224, n n¼20, 20, P P4 40.343). The 0.343). The group had a late age of onset of depression group had a late age of onset of depression (see Table 1 ), with only six subjects having (see Table 1 ), with only six subjects having onset before 60 years and only three before onset before 60 years and only three before 45 years. Using Mann-Whitney tests there 45 years. Using Mann-Whitney tests there was no difference between those who had was no difference between those who had received ( received (n n¼11) and those who had not 11) and those who had not received ( received (n n¼9) electroconvulsive therapy 9) electroconvulsive therapy ( (W W4 4108, 108, P P4 40.552), nor was there any 0.552), nor was there any difference between those who had ( difference between those who had (n n¼13) 13) and those who had not ( and those who had not (n n¼7) received anti-7) received antidepressant treatment within a week of depressant treatment within a week of death ( death (W W4 460, 60, P P4 40.275). Two suicides 0.275). Two suicides were included in the depression group were included in the depression group and none of the results was changed by and none of the results was changed by re-analysis without their inclusion. re-analysis without their inclusion.
DISCUSSION DISCUSSION
Key findings Key findings
Our main findings were of increased ICAMOur main findings were of increased ICAM-1 and VCAM-1 expression in the DLPFC in 1 and VCAM-1 expression in the DLPFC in the depression group. No differences in the the depression group. No differences in the expression of either CAM were found in expression of either CAM were found in the ACC and only a very modest and nonthe ACC and only a very modest and nonsignificant increase in ICAM-1 was found significant increase in ICAM-1 was found in the grey matter in the occipital cortex. in the grey matter in the occipital cortex. This increased expression of ICAM-1 and This increased expression of ICAM-1 and VCAM-1 showed marked specificity for the VCAM-1 showed marked specificity for the DLPFC in the depression group but little spe-DLPFC in the depression group but little specificity in the control group. These results are cificity in the control group. These results are consistent with the hypothesis that there are consistent with the hypothesis that there are ischaemia-induced inflammatory changes in ischaemia-induced inflammatory changes in the prefrontal cortex in depression. the prefrontal cortex in depression.
Increase in CAM expression
Increase in CAM expression is consistent with ischaemia is consistent with ischaemia measuring the expression of ICAM-1 and measuring the expression of ICAM-1 and VCAM-1 in the prefrontal cortex because VCAM-1 in the prefrontal cortex because these two molecules are increased by ischaethese two molecules are increased by ischaemia mia in vitro in vitro (Kim, 1996) and studies of (Kim, 1996) and studies of human ischaemic stroke have also shown human ischaemic stroke have also shown increased ICAM-1 expression in the microincreased ICAM-1 expression in the microvessels in association with the stroke lesions vessels in association with the stroke lesions (Lindsberg (Lindsberg et al et al, 1996) . There is increasing , 1996). There is increasing evidence that ischaemic brain damage deevidence that ischaemic brain damage develops over a much longer period than was velops over a much longer period than was previously believed (Stoll previously believed (Stoll et al et al, 1998) and , 1998) and our findings are therefore comparable with our findings are therefore comparable with a chronic reduction in cerebral perfusion a chronic reduction in cerebral perfusion to the DLPFC as well as with acute events. to the DLPFC as well as with acute events. A recent study in the DLPFC suggested that A recent study in the DLPFC suggested that elderly people with depression have inelderly people with depression have increased astrocytes (Miguel-Hidalgo creased astrocytes (Miguel-Hidalgo et al et al, , 2000) , which would be consistent with our 2000), which would be consistent with our finding of increased CAM expression in finding of increased CAM expression in the DLPFC because post-ischaemic inflamthe DLPFC because post-ischaemic inflammatory changes would increase astrocyte matory changes would increase astrocyte activity. Studies in younger patients with deactivity. Studies in younger patients with depression have reported a reduction in glia in pression have reported a reduction in glia in both the ACC (Ongur both the ACC (Ongur et al et al, 1998) and the , 1998) and the DLPFC (Rajkowska DLPFC (Rajkowska et al et al, 1999 (Rajkowska et al et al, ), which , 1999 , which could lead to a lack of glial support for neucould lead to a lack of glial support for neurons and increased neuronal vulnerability. rons and increased neuronal vulnerability. In elderly subjects chronic and/or acute In elderly subjects chronic and/or acute ischaemia could lead to an inflammatory ischaemia could lead to an inflammatory response causing neuronal damage and subresponse causing neuronal damage and subsequent increased glial activity. However, sequent increased glial activity. However, the extent to which these findings can be the extent to which these findings can be generalised to late-life depression in general generalised to late-life depression in general is unclear; our depression subjects were all is unclear; our depression subjects were all hospital patients who had had multiple hospital patients who had had multiple episodes of depression. episodes of depression.
Other possible explanations Other possible explanations for the findings for the findings
Although we carried out the study to test for Although we carried out the study to test for evidence of ischaemia, we cannot exclude evidence of ischaemia, we cannot exclude the possibility that depression mediates the possibility that depression mediates increases in CAM expression by other increases in CAM expression by other mechanisms, although the weight of evidmechanisms, although the weight of evidence associating depression with vascular disence associating depression with vascular diseases, especially in the elderly (Alexopoulos eases, especially in the elderly (Alexopoulos et al et al, 1997) , favours prefrontal ischaemia as , 1997), favours prefrontal ischaemia as the most likely explanation of the current the most likely explanation of the current results. Another possible pathway leading results. Another possible pathway leading to increased CAM expression could be the to increased CAM expression could be the increased circulating levels of cytokines increased circulating levels of cytokines (e.g. interleukin 1 and tumour necrosis fac-(e.g. interleukin 1 and tumour necrosis factor alpha), which have also been described tor alpha), which have also been described in depression (Connor & Leonard, 1998) . in depression (Connor & Leonard, 1998) . These cytokines stimulate the expression These cytokines stimulate the expression of CAMs and thus form a possible link. of CAMs and thus form a possible link.
The two groups were similar in age, The two groups were similar in age, gender, post-mortem delay and duration gender, post-mortem delay and duration of tissue fixation, and our analysis of the of tissue fixation, and our analysis of the data found no evidence that the results data found no evidence that the results could be explained by any of these factors. could be explained by any of these factors. In a previous study (Thomas In a previous study (Thomas et al et al, 2001) we , 2001) we found no differences in clinical measures of found no differences in clinical measures of vascular risk (e.g. hypertension) between vascular risk (e.g. hypertension) between the two groups and so the results do not the two groups and so the results do not appear to be due to such confounders. appear to be due to such confounders. Age of onset of depression did not affect Age of onset of depression did not affect the results, but because most of the the results, but because most of the depression group had a late age of onset depression group had a late age of onset we could not fully explore the extent to we could not fully explore the extent to which increased CAM expression might which increased CAM expression might differ in an early-onset group. We also differ in an early-onset group. We also found no evidence that treatments unique found no evidence that treatments unique to the depression group (antidepressants to the depression group (antidepressants and electroconvulsive therapy) could acand electroconvulsive therapy) could account for the group differences. Because count for the group differences. Because this was a case-note study we have been this was a case-note study we have been unable to examine fully all possible unable to examine fully all possible confounding factors and it is possible that confounding factors and it is possible that the up-regulation of the CAMs was due the up-regulation of the CAMs was due to some other factor or factors that we to some other factor or factors that we have been unable to exclude as a conhave been unable to exclude as a confounder. Increased CAM expression occurs founder. Increased CAM expression occurs in association with amyloid plaques in in association with amyloid plaques in Alzheimer's disease and after stroke (Kim, Alzheimer's disease and after stroke (Kim, 1996) , but our neuropathological assess-1996), but our neuropathological assessment has excluded such confounders as ment has excluded such confounders as explanations. We measured the expression explanations. We measured the expression of collagen IV to examine the possibility of collagen IV to examine the possibility that any differences in CAM expression that any differences in CAM expression were due to quantitative differences in the were due to quantitative differences in the cerebral endothelium (Kalaria & Hedera, cerebral endothelium (Kalaria & Hedera, 1995) but because no differences in 1995) but because no differences in collagen IV were found we have ruled out collagen IV were found we have ruled out this possible explanation as well. this possible explanation as well.
Importance of DLPFC Importance of DLPFC in depression in the elderly in depression in the elderly Our early findings (Thomas Our early findings (Thomas et al et al, 2000) , 2000) showed increased ICAM-1 expression in showed increased ICAM-1 expression in the DLPFC in depression. We have now the DLPFC in depression. We have now extended this by replicating the finding extended this by replicating the finding with VCAM-1 and found such increased with VCAM-1 and found such increased immunoreactivity to show some specificity immunoreactivity to show some specificity for the DLPFC that is not found in the for the DLPFC that is not found in the ACC. One possible explanation for this pat-ACC. One possible explanation for this pattern is that the depressive symptomatology tern is that the depressive symptomatology in our subjects was produced by disproporin our subjects was produced by disproportionate dysfunction in the frontal-subcortical tionate dysfunction in the frontal-subcortical circuit linking the DLPFC to the head of circuit linking the DLPFC to the head of the caudate nucleus rather than in the the caudate nucleus rather than in the circuit linking the ACC to the nucleus circuit linking the ACC to the nucleus accumbens (Alexander accumbens . Alter-, 1986) . Alternatively, because the DLPFC lies in an natively, because the DLPFC lies in an area of the prefrontal cortex between the area of the prefrontal cortex between the 13 3 13 3 territories of the anterior and middle cereterritories of the anterior and middle cerebral arteries, it appears to be more vulnerbral arteries, it appears to be more vulnerable to ischaemia, especially owing to able to ischaemia, especially owing to haemodynamic alterations (Chui & Willis, haemodynamic alterations (Chui & Willis, 1999) . Our results are consistent with this 1999). Our results are consistent with this because we found a higher CAM immunobecause we found a higher CAM immunoreactivity in the DLPFC in both groups, but reactivity in the DLPFC in both groups, but significantly more so for subjects with significantly more so for subjects with depression. These two alternatives could be depression. These two alternatives could be related because ischaemic damage to the related because ischaemic damage to the DLPFC would produce a characteristic DLPFC would produce a characteristic pattern of depressive symptomatology involpattern of depressive symptomatology involving retardation, poor concentration and ving retardation, poor concentration and dysexecutive failure. Such a pattern of execudysexecutive failure. Such a pattern of executive dysfunction has been associated with tive dysfunction has been associated with poor response to antidepressant treatment poor response to antidepressant treatment and with relapse and recurrence in elderly and with relapse and recurrence in elderly subjects with depression (Alexopoulos subjects with depression (Alexopoulos et al et al, , 2000) , which suggests that our findings have 2000), which suggests that our findings have clinical importance. clinical importance.
Although further investigation is reAlthough further investigation is required, our findings potentially have major quired, our findings potentially have major implications for the aetiology and manageimplications for the aetiology and management of depression in the elderly. If further ment of depression in the elderly. If further research shows that post-ischaemic inflamresearch shows that post-ischaemic inflammation is involved in late-life depression, mation is involved in late-life depression, the use of anti-inflammatory treatments the use of anti-inflammatory treatments (e.g. non-steroidal anti-inflammatory agents (e.g. non-steroidal anti-inflammatory agents or Cox-2 inhibitors) may become indicated or Cox-2 inhibitors) may become indicated to reduce inflammation and prevent further to reduce inflammation and prevent further tissue injury. tissue injury. Neurology, Neurosurgery and Psychiatry, , 70 70, 83^87. , 83^87.
4 4 CLINICAL IMPLICATIONS CLINICAL IMPLICATIONS
& & Inflammatory changes consistent with cerebral ischaemia were associated with Inflammatory changes consistent with cerebral ischaemia were associated with depression in our elderly subjects. depression in our elderly subjects.
& & These changes showed specificity for the dorsolateral prefrontal cortex, implying These changes showed specificity for the dorsolateral prefrontal cortex, implying that dysfunction here is particularly associated with depression in the elderly. that dysfunction here is particularly associated with depression in the elderly. This opens up the possibility for novel (anti-inflammatory and antivascular) treatments for late-life depression if these findings are confirmed. treatments for late-life depression if these findings are confirmed.
LIMITATIONS LIMITATIONS
& & Since this was a retrospective post-mortem study we were not able to examine
Since this was a retrospective post-mortem study we were not able to examine fully all the possible confounders. fully all the possible confounders.
& & Our subjects were all elderly (over 60 years old) and the extent to which our Our subjects were all elderly (over 60 years old) and the extent to which our results may apply to younger adults is not clear and needs further investigation. results may apply to younger adults is not clear and needs further investigation.
& & From our results we cannot determine causality; that is, whether depression leads
From our results we cannot determine causality; that is, whether depression leads to ischaemic changes or vice versa. to ischaemic changes or vice versa.
